You are here

  • Home
  • Archive
  • Volume 75, Issue 10
  • Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
D'Agostino M, Wakefield RJ, Berner-Hammer H on behalf of the OMERACT-EULAR-Ultrasound Task Force, et al
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study
Annals of the Rheumatic Diseases 2016;75:1763-1769.